There was a significant reduction in the expression of the proliferation marker Ki67 in the drug-treated mice (Figure 5A,B), and decreased expression of several cell cycle markers including CCND1 (Figure 5C,D), and E2F1 (Figure 5E,F), which could account for the reduction in tumor weight in response to Bay. This evidence concerns the gene E2F1 and neoplasm.